WT1 immunoprofiling and comparison of malignant mullerian mixed tumors of the female genital tract

International Journal of Gynecological Pathology

Volumn 29, Issue 5, 2010, Pages 452-458

  Franko, Angela ^a   Magliocco, Anthony M ^a,b   Duan, Quili ^b,c   Duggan, Máire A ^a  

^a Laboratory Medicine   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c TOM BAKER CANCER CENTRE   (Canada)

Author keywords

Immunohistochemical staining; Immunoprofile; Malignant Mullerian mixed tumor; WT1

Indexed keywords

WT1 PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARCINOSARCOMA; CELL STRUCTURE; CLINICAL ARTICLE; ENDOMETRIUM TUMOR; FEMALE; FEMALE GENITAL TRACT TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; MIXED MULLERIAN TUMOR; OVARY TUMOR; PERITONEUM TUMOR; PRIORITY JOURNAL; SCORING SYSTEM; TUMOR NECROSIS; TUMOR SUPPRESSOR GENE;

FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIXED TUMOR, MULLERIAN; WT1 PROTEINS;

EID: 77956208209     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181d55597     Document Type: Article

References (18)

1. Ariyoshi K, Kawauchi S, Nakano H, et al. Prognostic factors in ovarian carcinosarcoma: a clinicopathological and immuno-histochemical analysis of 23 cases. Histopathology 2000; 37:427-436
2. George E, Manivel JC, Dehner L, et al. Malignant mixed Mullerian tumors: an immunohistochemical study of 46 cases, with histogenetic considerations and clinical correlation. Human Pathol 1991;22:215-223
3. Geisinger K, Dabbs D, Marshall R, et al. Malignant mixed Mullerian tumors. An ultrastructural and immunohisto-chemical analysis with histogenic considerations. Cancer 1987; 59:1781-1790
4. Loeb DM, Sukumar S. The role of WT1 in oncogenesis: tumor suppressor or oncogene. Int J Hematol 2002;76:117-126
5. Scharnhorst V, van der Eb AJ, Jochemsen AG. WT1 proteins: function in growth and differentiation. Gene 2001;273:141-161
6. Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms tumor locus. Cell 1990;60:509-520
7. Shimizu M, Toki T, Takagi Y, et al. Immunohistochemical detection of the Wilms tumor gene (WT1) in epithelial ovarian tumors. Int J Gynecol Pathol 2000;19:158-163
8. Acs G, Pasha T, Zhang P. WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium. Int J Gynecol Pathol 2004; 23:110-118
9. Al-Hussaini M, Stockman A, Foster HM, et al. WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma. Histopathol 2004;44:109-115
10. Goldstein N, Uzieblo A. WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas. Am J Clin Pathol 2002;117:541-545
11. Dupont J, Wang X, Marshall D, et al. Wilm's Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray. Gynecol Oncol 2004;94: 449-455
12. Nakatsuka S, Oji Y, Horiuchi T, et al. Immunohistochemical detection of WT1 protein in a variety of cancer cells. Modern Pathol 2006; 19: 804-814
13. Coosemans A, Amini Nik S, Lambin S, et al. Upregulation of Wilms tumor 1 (WT1) in uterine sarcomas. Eur J Cancer 2007;43:1630-1637
14. Kourea H, Adonakis G, Androutsopoulos G, et al. Fallopian tube malignant mixed Mullerian tumor (carcinosarcoma): a case report with immunohistochemical profiling. Eur J Gynecol Oncol 2008;29:538-542
15. Ronnett BM, Zaino RJ, Hedrick Ellenson L, et al. Endome-trial carcinoma. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. 5th ed. New York, USA; Springer: 2002: 538-541
16. Boenisch T, Farmilo AJ, Stead RH. Handbook: Immunochemical Staining Methods, 3rd Edition. Carpinteria: DakoCytomation Corporation; 2001.
17. Bergman L, Miething C, Maurer U, et al. High levels of Wilms tumor gene (WT1) mRNA in acute myeloid leukemias are associated with a worse long term outcome. Blood 1997;90: 1217-1225
18. Carpentieri DF, Nichols K, Chou PM, et al. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors. Mod Pathol 2002;15: 1080-1086